MeiraGTx Holdings Hits New 52-Week High of $12.56, Up 161.25%

MeiraGTx Holdings Plc has reached a significant milestone by hitting a new 52-week high of USD 12.56 on June 29, 2026. This achievement marks a notable increase from its 52-week low of USD 6.31, reflecting a remarkable year-over-year performance of 161.25%. In comparison, the S&P 500 has shown a performance of 20.53% during the same period, highlighting MeiraGTx's strong position within the Pharmaceuticals & Biotechnology sector. With a market capitalization of USD 613 million, MeiraGTx is classified as a small-cap company. Despite being loss-making, it boasts an impressive return on equity of 415.93%, indicating effective management of its equity base. However, the company does not offer a dividend yield, and its price-to-book ratio stands at -15.12, suggesting a unique valuation perspective in the market. As MeiraGTx continues to navigate the competitive landscape of the biotechnology industry, this recent price achievement underscores its potential and performance metrics that are attracting attention in the financial community.